Abstract
In their commentary about our meta-analysis of the efficacy of pneumococcal polysaccharide vaccine, [1][1] Ross Andrews and Sarah Moberley stated that our conclusions go beyond the evidence presented and that a need exists for new trials to contribute more data, rather than repeated analyses of
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
